par Schulman, Claude
Référence European urology. Supplement, 5, 4 SPEC. ISS., page (399-400)
Publication Publié, 2006-04
Article révisé par les pairs
Résumé : The management of patients with lower urinary tract symptoms due to benign prostatic enlargement is based on a correct understanding of the pathophysiology of the disease. Permixon™ has a significant role in the treatment for these patients. © 2006 Elsevier B.V. All rights reserved.